Neo-adjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study' NADIM trial

Authors :: M. Majem Tarruella
E. Nadal
N. Vinolas Segarra
D. Vicente Baz
I.C. Barneto Aranda
A. Insa Molla
M. Guillot Morales
M. Provencio Pulla
R. Bernabe Caro
J. de Castro
Guillermo Lopez-Vivanco
M. Domine Gomez
Jose-Luis Gonzalez-Larriba
J. Casal Rubio
A. Martinez Marti
M. Cobo Dols
B. Massuti Sureda
V. Calvo De Juan
D. Rodriguez Abreu
C. Camps Herrero
Source :: Annals of Oncology. 28:v456
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine.medical_treatment
medicine
Stage IIIA Non-Small Cell Lung Cancer
Hematology
business
Adjuvant
Chemo immunotherapy

Full Text Access

Tools